Open access
Open access
Powered by Google Translator Translator

Pediatrics – Cardiology

Cohort Study | Younger age at hypertrophic cardiomyopathy diagnosis, male sex among predictors of developing LV systolic dysfunction

11 Aug, 2023 | 15:16h | UTC

Left Ventricular Systolic Dysfunction in Patients Diagnosed With Hypertrophic Cardiomyopathy During Childhood: Insights From the SHaRe Registry – Circulation

 

Commentary on Twitter

 


Scientific Statement | Addressing childhood obesity to reduce adult CV risk through lifestyle

27 Jul, 2023 | 13:03h | UTC

Lifestyle interventions to change trajectories of obesity-related cardiovascular risk from childhood onset to manifestation in adulthood: a joint scientific statement of the task force for childhood health of the European Association of Preventive Cardiology and the European Childhood Obesity Group – European Journal of Preventive Cardiology

News Release: How to stop obese children having heart disease in adulthood – European Society of Cardiology

 


USPSTF Statement | Evidence lacking for lipid disorders screening in asymptomatic children and adolescents

20 Jul, 2023 | 11:13h | UTC

Screening for Lipid Disorders in Children and Adolescents: US Preventive Services Task Force Recommendation Statement – JAMA

Evidence Report: Screening for Lipid Disorders in Children and Adolescents: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA

Editorial: Still “on the Fence” About Universal Childhood Lipid Screening: The USPSTF Reaffirms an I Statement – JAMA

Patient Page: Screening for Lipid Disorders in Children and Adolescents – JAMA

Commentary: USPSTF: Screening Kids for Lipid Disorders Still Needs More Data – TCTMD

 


Nationwide Cohort Study | Adolescent hypertension linked with increased stroke risk in young adulthood

18 Jul, 2023 | 13:49h | UTC

Adolescent Hypertension Is Associated With Stroke in Young Adulthood: A Nationwide Cohort of 1.9 Million Adolescents – Stroke

Commentary: The Relationship Between Adolescent Hypertension and Stroke Risk After Age 40 Years – Neurology Advisor

 


Guidelines and recommendations for performance of the fetal echocardiogram

17 Jul, 2023 | 13:45h | UTC

Guidelines and Recommendations for Performance of the Fetal Echocardiogram: An Update from the American Society of Echocardiography

 


Podcast | EKG pearls in children

11 Jul, 2023 | 13:50h | UTC

#88: The EKG with Mike Fah-EY – The Cribsiders

 


Consensus Statement | Anatomy, imaging, and nomenclature of congenital aortic root malformations

21 Jun, 2023 | 13:25h | UTC

Expert Consensus Statement: Anatomy, Imaging, and Nomenclature of Congenital Aortic Root Malformations – Cardiology in the Young

 


AHA Scientific Statement | Treatment strategies for cardiomyopathy in children

12 Jun, 2023 | 13:49h | UTC

Treatment Strategies for Cardiomyopathy in Children: A Scientific Statement From the American Heart Association – Circulation

News Releases:

Identifying the cause of heart muscle disease in children is key to effective treatment – American Heart Association

Children with heart muscle disease need more personalized treatment plans – American Heart Association

Top Things to Know: Treatment Strategies for Cardiomyopathy in Children – American Heart Association

 


Review | Pediatric pericarditis

9 May, 2023 | 14:42h | UTC

Pediatric Pericarditis: Update – Current Cardiology Reports

 


Preliminary study show wireless pacemakers may be safe and effective for children with bradycardia

24 Apr, 2023 | 13:27h | UTC

Transcatheter Leadless Pacing in Children: A PACES Collaborative Study in the Real-World Setting – Circulation: Arrhythmia and Electrophysiology

News Release: Wireless pacemakers may be safe, effective for children with irregular heart rhythms – American Heart Association

Commentary: Leadless Pacemakers Could Prove Useful for Pediatric Patients with Arrhythmias – HCP Live

 


Joint statement for assessing and managing high blood pressure in children and adolescents

19 Apr, 2023 | 13:26h | UTC

Chapter 1: How to correctly measure blood pressure in children and adolescents – Frontiers in Pediatrics

Chapter 2: How to manage high blood pressure in children and adolescents – Frontiers in Pediatrics

Related:

AHA Scientific Statement | Pediatric primary hypertension: An underrecognized condition

AHA Scientific Statement: Ambulatory blood pressure monitoring in children and adolescents.

Hypertension in Children and Adolescents: A Position Statement From a Panel of Multidisciplinary Experts Coordinated by the French Society of Hypertension – Frontiers in Pediatrics

USPSTF Statement: Insufficient evidence to recommend screening for high blood pressure in children and adolescents

 


Cohort Study | Value of screening for the risk of sudden cardiac death in young competitive athletes

12 Apr, 2023 | 13:11h | UTC

Value of screening for the risk of sudden cardiac death in young competitive athletes – European Heart Journal

Editorial: Optimizing pre-participation screening to prevent tragedy in young athletes: moving from if to how – European Heart Journal

 


AAP Clinical Report | Health supervision for children and adolescents with Marfan syndrome

10 Apr, 2023 | 13:51h | UTC

Health Supervision for Children and Adolescents With Marfan Syndrome – Pediatrics

 

Commentary on Twitter

 


Rheumatic heart disease: JACC focus seminar

6 Apr, 2023 | 13:17h | UTC

Rheumatic Heart Disease: JACC Focus Seminar – Journal of the American College of Cardiology

 


AHA Scientific Statement | Pediatric primary hypertension: An underrecognized condition

3 Apr, 2023 | 14:05h | UTC

Pediatric Primary Hypertension: An Underrecognized Condition: A Scientific Statement From the American Heart Association – Hypertension

Top Things to Know: Pediatric Primary Hypertension: An Underrecognized Condition – American Heart Association

News Release: Children with high blood pressure often become adults with high blood pressure – American Heart Association

Commentaries:

The Birth of Pediatric Primary Hypertension – American Heart Association

AHA Highlights Pediatric Hypertension in Scientific Statement – HCP Live

 


Recommendations for cardiac point-of-care ultrasound in children

10 Mar, 2023 | 14:35h | UTC

Recommendations for Cardiac Point-of-Care Ultrasound in Children: A Report from the American Society of Echocardiography – Journal of the American Society of Echocardiography

 


Myocarditis or pericarditis events after BNT162b2 vaccination in individuals aged 12 to 17 years in Ontario, Canada

7 Mar, 2023 | 13:13h | UTC

Summary:

A population-based cohort study was conducted to estimate the incidence of reported myocarditis or pericarditis after BNT162b2 vaccination in adolescents aged 12 to 17 years in Ontario, Canada, and to describe the clinical information associated with these events. The study analyzed data from 1.65 million doses of BNT162b2 vaccinations administered between December 14, 2020, and November 21, 2021.

According to the study, 77 adolescents were reported to have developed myocarditis or pericarditis after receiving the vaccine, and there was a greater occurrence of these events among those aged 16 to 17 years compared to those aged 12 to 15 years. Additionally, adolescents with shorter intervals between vaccine doses had a higher incidence of myocarditis or pericarditis.

Most cases of myocarditis and pericarditis were mild, and the adolescents required either no treatment or were treated conservatively with nonsteroidal anti-inflammatory drugs.

Article: Myocarditis or Pericarditis Events After BNT162b2 Vaccination in Individuals Aged 12 to 17 Years in Ontario, Canada – JAMA Pediatrics

Commentary: Does the incidence of reported myocarditis or pericarditis after BNT162b2 vaccination vary by age, sex, and inter-dose interval among adolescents aged 12 to 17? – News Medical

 


Maternal diabetes and overweight as risk factors for congenital heart defects in offspring – A nationwide register study from Finland

3 Mar, 2023 | 13:51h | UTC

Summary: The study aimed to determine the association between maternal diabetes and overweight/obesity and the risk of congenital heart defects (CHDs) in offspring. The study analyzed data from all children born in Finland between 2006 and 2016 and their mothers. Maternal type 1 diabetes (T1DM) was found to be associated with a significantly increased risk for any CHD, with an odds ratio of 3.71, whereas maternal overweight and obesity were associated with only a slightly increased risk for complex defects and left ventricular outflow tract obstruction. Maternal diabetes was responsible for 3.0% of offspring’s CHD, while maternal overweight and obesity were responsible for 0.7%, indicating weaker associations between maternal overweight and obesity and CHD in the offspring than previously reported.

[Preprint] Maternal diabetes and overweight as risk factors for congenital heart defects in offspring – A nationwide register study from Finland – medRxiv

 

Commentary from the author on Twitter

 


M-A | Thromboprophylaxis in patients with Fontan circulation

2 Mar, 2023 | 12:57h | UTC

Thromboprophylaxis in Patients With Fontan Circulation – Journal of the American College of Cardiology (link to abstract – $ for full-text)

Commentary: Thromboprophylaxis in Patients With Fontan Circulation – American College of Cardiology

 

Commentary from the author on Twitter (thread – click for more)

 


Brief Review | Acute rheumatic fever: recent advances

2 Mar, 2023 | 12:41h | UTC

Acute Rheumatic Fever: Recent Advances – The Pediatric Infectious Disease Journal (free for a limited period)

 


Retrospective Cohort | Lifetime risk of comorbidity in patients with simple congenital heart disease

17 Feb, 2023 | 12:57h | UTC

Lifetime risk of comorbidity in patients with simple congenital heart disease: a Danish nationwide study – European Heart Journal

Editorial: Addressing comorbidities in simple congenital heart disease: a critical step to achieve optimal long-term outcomes – European Heart Journal

 

Commentary on Twitter

 


SR | Intravenous immunoglobulin for the treatment of Kawasaki disease

7 Feb, 2023 | 13:58h | UTC

Intravenous immunoglobulin for the treatment of Kawasaki disease – Cochrane Library

Summary: Immunoglobulin treatment for Kawasaki disease – Cochrane Library

Related:

Analysis of Coronary Arterial Aneurysm Regression in Patients With Kawasaki Disease by Aneurysm Severity: Factors Associated With Regression – Journal of the American Heart Association

Analysis of Age, Sex, Lack of Response to Intravenous Immunoglobulin, and Development of Coronary Artery Abnormalities in Children With Kawasaki Disease in Japan – JAMA Network Open

Systematic Review: Corticosteroids for the treatment of Kawasaki disease in children.

Pharmacologic interventions for Kawasaki disease in children: A network meta-analysis of 56 randomized controlled trials.

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease

Anti-inflammatory Treatment of Kawasaki Disease: Comparison of Current Guidelines and Perspectives – Frontiers in Medicine

 


Cohort Study | Analysis of factors associated with coronary arterial aneurysm regression in patients with Kawasaki disease

7 Feb, 2023 | 13:56h | UTC

Analysis of Coronary Arterial Aneurysm Regression in Patients With Kawasaki Disease by Aneurysm Severity: Factors Associated With Regression – Journal of the American Heart Association

Related:

Intravenous immunoglobulin for the treatment of Kawasaki disease – Cochrane Library

Analysis of Age, Sex, Lack of Response to Intravenous Immunoglobulin, and Development of Coronary Artery Abnormalities in Children With Kawasaki Disease in Japan – JAMA Network Open

Systematic Review: Corticosteroids for the treatment of Kawasaki disease in children.

Pharmacologic interventions for Kawasaki disease in children: A network meta-analysis of 56 randomized controlled trials.

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease

Anti-inflammatory Treatment of Kawasaki Disease: Comparison of Current Guidelines and Perspectives – Frontiers in Medicine

 


SR | Paracetamol for patent ductus arteriosus in preterm or low birth weight infants

3 Feb, 2023 | 13:47h | UTC

Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants – Cochrane Library

Summary: What are the benefits and risks of paracetamol (acetaminophen) for patent ductus arteriosus (PDA, a blood vessel necessary for fetal survival) in preterm and low birth weight infants? – Cochrane Library

 

Commentary on Twitter

 


Cohort Study | Lifetime burden of morbidity in patients with isolated congenital ventricular septal defect

1 Feb, 2023 | 13:02h | UTC

Lifetime Burden of Morbidity in Patients With Isolated Congenital Ventricular Septal Defect – Journal of the American Heart Association

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.